These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1970847)

  • 1. Effects of an alpha 2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse (C57BL/6J ob/ob).
    Saperstein R; Chapin EW; Brady EJ; Slater EE
    Metabolism; 1990 May; 39(5):445-51. PubMed ID: 1970847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to insulin-releasing and glucoregulatory effects of dynorphin A1-13 and U 50488h in ob/ob versus lean mice.
    Khawaja XZ; Green IC; Thorpe JR; Bailey CJ
    Diabetes; 1990 Oct; 39(10):1289-97. PubMed ID: 1976559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
    Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR
    Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice.
    Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH
    Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mouse.
    Kuhn CM; Cochrane C; Feinglos MN; Surwit RS
    Pharmacol Biochem Behav; 1987 Mar; 26(3):491-5. PubMed ID: 3554269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of dark onset feeding in obese mice (genotype ob/ob) following central injection of norepinephrine and clonidine.
    Currie PJ; Wilson LM
    Eur J Pharmacol; 1993 Mar; 232(2-3):227-34. PubMed ID: 8467860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood glucose and serum insulin levels in lean and genetically obese mice.
    Beloff-Chain A; Freund N; Rookledge KA
    Horm Metab Res; 1975 Sep; 7(5):374-8. PubMed ID: 1183915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice.
    Fukudo S; Virnelli S; Kuhn CM; Cochrane C; Feinglos MN; Surwit RS
    Diabetes; 1989 Nov; 38(11):1433-8. PubMed ID: 2576006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ
    Horm Metab Res; 1981 Oct; 13(10):556-60. PubMed ID: 7028589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of adrenalectomy on the metabolism of glucose in obese (C57 Bl/6J ob/ob) mice.
    Wittmers LE; Haller EW
    Metabolism; 1983 Dec; 32(12):1093-100. PubMed ID: 6645960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of glucose homeostasis and hepatic insulin resistance in ob/ob mice given oral molybdate.
    Reul BA; Becker DJ; Ongemba LN; Bailey CJ; Henquin JC; Brichard SM
    J Endocrinol; 1997 Oct; 155(1):55-64. PubMed ID: 9390006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice.
    Hwang IK; Go VL; Harris DM; Yip I; Kang KW; Song MK
    Diabetes Obes Metab; 2003 Sep; 5(5):317-24. PubMed ID: 12940869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired insulin-like growth factor I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse.
    Cascieri MA; Slater EE; Vicario PP; Green BG; Bayne ML; Saperstein R
    Diabetologia; 1989 Jun; 32(6):342-7. PubMed ID: 2547681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent.
    Murakami N; Ohta M; Hashimoto K; Kato K; Mizota M; Miwa I; Okuda J; Inoue G; Kuzuya H; Nakao K; Imura H
    Eur J Pharmacol; 1996 May; 304(1-3):129-34. PubMed ID: 8813594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.
    Alberts P; Nilsson C; Selen G; Engblom LO; Edling NH; Norling S; Klingström G; Larsson C; Forsgren M; Ashkzari M; Nilsson CE; Fiedler M; Bergqvist E; Ohman B; Björkstrand E; Abrahmsen LB
    Endocrinology; 2003 Nov; 144(11):4755-62. PubMed ID: 12960099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.